AwardedCzechiaGoods
Dodávky léčivých přípravků s účinnou látkou MIRVETUXIMAB SORAVTANSIN
- Published
- Published 8 April 2026
- Deadline
- Closed 11 May 2026
Overview
Fakultní nemocnice Brno procured supplies of the medicinal product with active ingredient mirvetuximab soravtansin through a framework purchase agreement. The contract was awarded to AbbVie s.r.o. for 27,088,560 CZK on May 27, 2026.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 8 April 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- CZK 27,088,560
- Award date
- 27 May 2026
- Contract period
- 10 June 2026 → 9 June 2030
- AbbVie s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 June 2026
Contract Notice
8 April 2026
Contracting authority
Fakultní nemocnice Brno
Procuring entityBrno, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.